Lorazepam and Retacrit drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Retacrit (epoetin alfa-epbx). Common drug interactions include death among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Retacrit. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Retacrit?

Retacrit has active ingredients of epoetin alfa-epbx. eHealthMe is studying from 2,196 Retacrit users. Check the latest studies of Retacrit.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

20 people who take Lorazepam and Retacrit together, and have interactions are studied.

Lorazepam and Retacrit drug interactions.

What are the common drug interactions of Lorazepam and Retacrit, by gender? *:

female:

Death
Confusional state
Decreased appetite
Disease progression
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fall
Febrile neutropenia (fever with reduced white blood cells)
Hospitalisation
Irritable bowel syndrome
Malaise (a feeling of general discomfort or uneasiness)

male:

Fatigue (feeling of tiredness)
Alcoholic pancreatitis
Dizziness
Dysphonia (speech disorder attributable to a disorder of phonation)
Eye irritation
Foreign body sensation in eyes (feeling of something in eye)
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Hypertension (high blood pressure)
Neoplasm progression (growth of tumour)
Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Lorazepam and Retacrit, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Death
Fatigue (feeling of tiredness)
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Hospitalisation
Pneumonia necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs)
Venous thrombosis (blood clot (thrombus) that forms within a vein)
Anaemia (lack of blood)
Confusional state
Disease progression
Disorientation (disability in which the senses of time, direction, and recognition of people and places)

What are the existing conditions these people have? *

Anaemia (lack of blood): 3 people, 15.00%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 2 people, 10.00%
Multiple Myeloma (cancer of the plasma cells): 2 people, 10.00%
Rashes (redness): 2 people, 10.00%
Insomnia (sleeplessness): 2 people, 10.00%
Rectal Cancer (cancer of rectum): 1 person, 5.00%
High Blood Pressure: 1 person, 5.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 5.00%
Breast Cancer: 1 person, 5.00%
Cystic Fibrosis (disease of the secretary glands): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Retacrit?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously